{"version":"1.0","type":"link","title":"Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial.","author_name":"Leachman SA 외","author_url":"https://prs-insight.online/author/Leachman%20SA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168499","thumbnail_width":1200,"thumbnail_height":630}